Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Alexion Pharm Inc (ALXN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 28,573,786
  • Shares Outstanding, K 225,150
  • Annual Sales, $ 3,084 M
  • Annual Income, $ 399,000 K
  • 36-Month Beta 1.33
  • Price/Sales 8.81
  • Price/Cash Flow 20.10
  • Price/Book 3.11

Price Performance

See More
Period Period Low Period High Performance
1-Month
113.42 +12.66%
on 04/07/17
128.74 -0.75%
on 04/28/17
+9.25 (+7.80%)
since 03/28/17
3-Month
113.42 +12.66%
on 04/07/17
138.21 -7.55%
on 02/16/17
-1.45 (-1.12%)
since 01/27/17
52-Week
109.12 +17.10%
on 12/13/16
157.02 -18.62%
on 06/02/16
-14.75 (-10.35%)
since 04/28/16

Most Recent Stories

More News
Alexion (ALXN) Tops Q1 Earnings, Revenues; Ups '17 View

Alexion Pharmaceuticals, Inc.'s (ALXN) first-quarter 2017 earnings (including stock-based compensation expense) of $1.20 per share compared with the year ago earnings of 76 cents. The reported figure surpassed...

HSKA : 108.25 (+2.88%)
GALE : 0.59 (-4.84%)
INFI : 2.15 (+2.38%)
ALXN : 127.78 (+0.69%)
Alexion (ALXN) Tops Q1 Earnings, Sales; Shares Up

Alexion surpassed earnings and sales expectations in the first quarter of 2017.

ALXN : 127.78 (+0.69%)
Alexion Reports First Quarter 2017 Results

--Revenue Growth Benefited from Continued Strong Volume Growth of Soliris(R) In Core Markets

ALXN : 127.78 (+0.69%)
Stocks Give an Encore Performance

Stocks Give an Encore Performance

CELG : 124.05 (+0.06%)
DHI : 32.89 (-1.08%)
TEX : 34.98 (-1.77%)
LNCE : 35.26 (-0.45%)
BEAT : 32.90 (+1.39%)
LEA : 142.66 (+0.05%)
CVGI : 8.89 (-0.78%)
WYNN : 123.01 (-1.20%)
WMB : 30.63 (-0.39%)
JUNO : 24.94 (+0.28%)
CTB : 38.30 (-2.17%)
EW : 109.67 (unch)
LMT : 269.45 (-0.62%)
APC : 57.02 (-0.18%)
PCH : 45.05 (-4.05%)
HDSN : 7.10 (+0.28%)
NEM : 33.81 (+2.73%)
LRCX : 144.85 (-1.46%)
INCY : 124.28 (+0.09%)
GILD : 68.55 (-0.04%)
FB : 150.25 (+1.73%)
PTC : 54.05 (-0.06%)
ALXN : 127.78 (+0.69%)
Alexion Pharmaceuticals Rises 1.09% on Heavy Volume: Watch For Potential Pullback

Alexion Pharmaceuticals (NASDAQ:ALXN) traded in a range yesterday that spanned from a low of $119.47 to a high of $122.07. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day...

ALXN : 127.78 (+0.69%)
How These Biotech Stocks are Faring? -- ACADIA Pharma, Alexion Pharma, TG Therapeutics, and Esperion Therapeutics

On Friday, April 21, 2017, the NASDAQ Composite, the Dow Jones Industrial Average, and the S&P 500 edged lower at the closing bell. Seven out of nine sectors ended last Friday's trading session in bearish...

TGTX : 11.05 (-7.53%)
ESPR : 35.75 (+0.68%)
ACAD : 34.33 (+1.48%)
ALXN : 127.78 (+0.69%)
Alexion (ALXN) Q1 Earnings: Can the Stock Pull a Surprise?

Alexion Pharmaceuticals, Inc. (ALXN) is scheduled to report first quarter 2017 results on Apr 27, before the opening bell.

GILD : 68.55 (-0.04%)
ICPT : 112.35 (-0.78%)
AMGN : 163.32 (+0.37%)
ALXN : 127.78 (+0.69%)
Blog Coverage CytRx Announces FDA's Approval for New Drug Application

Upcoming AWS Coverage on Alexion Pharmaceuticals Post-Earnings Results

CYTR : 0.51 (-25.00%)
ALXN : 127.78 (+0.69%)
After Yesterday's Rally of 1.39% Shares Could Potentially Pullback

Alexion Pharmaceuticals (NASDAQ:ALXN) traded in a range yesterday that spanned from a low of $118.02 to a high of $120.15. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day...

ALXN : 127.78 (+0.69%)
Biotech Stock Roundup: FDA CRL Hits Incyte, Pipeline Setbacks Weigh on OncoMed

Incyte's (INCY) shares were hit by the FDA's complete response letter (CRL) for the company's rheumatoid arthritis drug.

MDCO : 49.32 (+1.52%)
BMRN : 95.84 (-0.44%)
OMED : 3.94 (-1.50%)
INCY : 124.28 (+0.09%)
IONS : 48.19 (+1.32%)
ALXN : 127.78 (+0.69%)
BIIB : 271.21 (-1.94%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More

Business Summary

Alexion Pharmaceuticals develops pharmaceutical products for the treatment of heart disease, and inflammation, diseases of the immune system and cancer in humans. The company's lead product candidates are genetically altered antibodies that target specific diseases which arise when the human immune system...

See More

Support & Resistance

2nd Resistance Point 130.49
1st Resistance Point 129.13
Last Price 127.78
1st Support Level 126.03
2nd Support Level 124.29

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.